1. Home
  2. EVO vs SKE Comparison

EVO vs SKE Comparison

Compare EVO & SKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • SKE
  • Stock Information
  • Founded
  • EVO 1993
  • SKE 1979
  • Country
  • EVO Germany
  • SKE Canada
  • Employees
  • EVO N/A
  • SKE N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • SKE Precious Metals
  • Sector
  • EVO Health Care
  • SKE Basic Materials
  • Exchange
  • EVO Nasdaq
  • SKE Nasdaq
  • Market Cap
  • EVO 1.1B
  • SKE 960.9M
  • IPO Year
  • EVO 2021
  • SKE N/A
  • Fundamental
  • Price
  • EVO $5.44
  • SKE $7.87
  • Analyst Decision
  • EVO Buy
  • SKE
  • Analyst Count
  • EVO 2
  • SKE 0
  • Target Price
  • EVO $5.90
  • SKE N/A
  • AVG Volume (30 Days)
  • EVO 362.8K
  • SKE 325.6K
  • Earning Date
  • EVO 11-06-2024
  • SKE 11-22-2024
  • Dividend Yield
  • EVO N/A
  • SKE N/A
  • EPS Growth
  • EVO N/A
  • SKE N/A
  • EPS
  • EVO N/A
  • SKE N/A
  • Revenue
  • EVO $866,665,179.00
  • SKE N/A
  • Revenue This Year
  • EVO $4.56
  • SKE N/A
  • Revenue Next Year
  • EVO $13.44
  • SKE $50.00
  • P/E Ratio
  • EVO N/A
  • SKE N/A
  • Revenue Growth
  • EVO N/A
  • SKE N/A
  • 52 Week Low
  • EVO $2.85
  • SKE $3.29
  • 52 Week High
  • EVO $12.00
  • SKE $10.33
  • Technical
  • Relative Strength Index (RSI)
  • EVO 69.82
  • SKE 34.54
  • Support Level
  • EVO $4.34
  • SKE $7.32
  • Resistance Level
  • EVO $4.95
  • SKE $9.54
  • Average True Range (ATR)
  • EVO 0.21
  • SKE 0.40
  • MACD
  • EVO 0.12
  • SKE -0.27
  • Stochastic Oscillator
  • EVO 89.72
  • SKE 18.86

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About SKE Skeena Resources Limited

Skeena Resources Ltd is a Canadian mining exploration company focused on developing prospective precious and base metal properties in the Golden Triangle of northwest British Columbia, Canada. The company's primary activity is the exploration and development of the past-producing Eskay Creek mine acquired from Barrick.

Share on Social Networks: